SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008706
Filing Date
2017-11-09
Accepted
2017-11-09 16:11:23
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avxs-20170930x10q.htm 10-Q 1064007
2 EX-10.1 avxs-20170930ex101c25217.htm EX-10.1 103074
3 EX-31.1 avxs-20170930ex311061222.htm EX-31.1 16462
4 EX-31.2 avxs-20170930ex3121ea7a4.htm EX-31.2 16588
5 EX-32.1 avxs-20170930ex3218827e1.htm EX-32.1 9958
  Complete submission text file 0001558370-17-008706.txt   4244055

Data Files

Seq Description Document Type Size
6 EX-101.INS avxs-20170930.xml EX-101.INS 779722
7 EX-101.SCH avxs-20170930.xsd EX-101.SCH 32442
8 EX-101.CAL avxs-20170930_cal.xml EX-101.CAL 29108
9 EX-101.DEF avxs-20170930_def.xml EX-101.DEF 152862
10 EX-101.LAB avxs-20170930_lab.xml EX-101.LAB 327462
11 EX-101.PRE avxs-20170930_pre.xml EX-101.PRE 261381
Mailing Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015 972-725-7797
AveXis, Inc. (Filer) CIK: 0001652923 (see all company filings)

IRS No.: 901038273 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37693 | Film No.: 171190934
SIC: 2836 Biological Products, (No Diagnostic Substances)